Statens Serum Institut (SSI) consists of a management board, four health priority areas and staff units – all with their own departments.

SSI - Organisation chart

See the organisation chart as a pdf.

Management board

Ole Jensen (Executive Vice President, appointed as Managing Director ad interim)
Helle Birk Krogsgaard (Chief Financial Officer)
Anne-Marie Vangsted (TestCenter Danmark)
Kåre Mølbak (Executive Vice President) 


Corporate Affairs
Center for Biosecurity & Biopreparedness 

Business Support & Campus (Helle Birk Krogsgaard, Chief Financial Officer)

Business Development
QA & Compliance

Infectious Disease Preparedness (Kåre Mølbak, Executive Vice President)

Infectious Disease Preparedness
Infectious Disease Epidemiology & Prevention
Bacteria, Parasites & Fungi
Virus & Microbiological Special Diagnostics
International Reference Laboratory of Mycobacteriology
Prediagnostics & Service

Biobank & Biomarkers (David Hougaard, Executive Vice President ad interim)

Biobank & Biomarkers
Congenital Disorders
Danish National Biobank

Research - vaccines (Peter L. Andersen, Research Director)

Infectious Disease Immunology
Vaccine Development

Research - epidemiology (N.N., Executive Vice President)

Epidemiology research